Hypertensive encephalopathy: Mechanisms, clinical features, and treatment.
D000818:Animals; D001921:Brain / Q000473:pathology; D001927:Brain Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D003937:Diagnosis, Differential; D003981:Diazoxide / Q000008:administration & dosage / Q000627:therapeutic use; D004569:Electroencephalography; D005665:Furosemide / Q000627:therapeutic use; D005730:Ganglionic Blockers / Q000009:adverse effects; D006801:Humans; D006830:Hydralazine / Q000008:administration & dosage / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D051381:Rats
D005730:Ganglionic Blockers; D006830:Hydralazine; D005665:Furosemide; D003981:Diazoxide